FDA Introduces New Plan to Speed Up Custom-Made Treatments for Rare Diseases
The U.S. Food and Drug Administration (FDA) has introduced a new plan to help speed up the development of custom-made […]
The U.S. Food and Drug Administration (FDA) has introduced a new plan to help speed up the development of custom-made […]
The Centers for Disease Control and Prevention (CDC) has recently updated its website to suggest that there might be a
A new version of the medicine Simponi, called Gobivaz, has been approved in Europe. This new version is for people
In recent years, new Alzheimer’s drugs have had a slow start, but they are now gaining momentum. Sales of Eli
The results of clinical trials are crucial for biotechnology companies. Good results can confirm a company’s plans and boost its
The Centers for Disease Control and Prevention (CDC) has recently updated their website. They now say that there might be
Welcome to Biotech Spotlight, where we talk about companies creating groundbreaking technologies and products. Today, we’re discussing Imunon, a company
Eisai, a pharmaceutical company, has shared new clinical data from a study called Clarity AD. This study looked at adults
Two big drug companies, Bristol Myers Squibb and Johnson & Johnson, have stopped a major study on a new experimental
MSD, a large pharmaceutical company, has agreed to buy Cidara Therapeutics for $9.2 billion. This deal will add a new